Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Catalyst Biosciences Inc (NASDAQ:CBIO)

1.21
Delayed Data
As of Sep 30
 0.00 / 0.00%
Today’s Change
1.12
Today|||52-Week Range
6.04
-61.34%
Year-to-Date
No recent news for Catalyst Biosciences Inc.

Today’s Trading

Previous close1.21
Today’s open1.20
Day’s range1.15 - 1.24
Volume28,359
Average volume (3 months)149,084
Market cap$14.3M
Dividend yield47.05%
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+50.96%
Earnings growth (this year)+58.11%
Earnings growth (next 5 years)+35.40%
Revenue growth (last year)+536.36%
P/E ratio0.1
Price/Sales7.92
Price/Book0.44

Competitors

 Today’s
change
Today’s
% change
OGXIOncoGenex Pharmaceut...+0.04+7.87%
CLRBCellectar Bioscience...0.000.00%
JAGXJaguar Animal Health...+0.02+1.59%
RTTRRitter Pharmaceutica...+0.08+5.00%
Data as of 3:59pm ET, 09/30/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$1.8M
Annual profit (last year)-$14.8M
Net profit margin-843.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nassim Usman
Chief Financial Officer &
Head-Investor Relations
C. Fletcher Payne
Corporate headquarters
South San Francisco, California

Forecasts

Search for Jobs